Martin Christner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Martin Christner has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Holger Rohde
Institute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf
3 shared publications - Benjamin Berinson
Institute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf
2 shared publications - Manuel Wolters
Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf
2 shared publications Martin Aepfelbacher
Institut für Medizinische Mikrobiologie, Virologie und Hygiene, Universitätsklinikum Hamburg-Eppendorf (UKE), Hamburg, Germany
2 shared publicationsAndreas Heyer
Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany
1 shared publication- Angela Schulz
Department of Pediatrics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
1 shared publication
Latest Publications
- Open Access
Evaluation of a commercial 16S rDNA PCR assay (UMD-SelectNA, Molzym) for pathogen detection from cardiac tissue specimens
The detection of bacteria in cardiac tissue, vegetations, or explanted prosthetic valves using nucleic acid amplification tests, such as 16S rDNA amplicon sequencing (16S rDNA PCR), has been incorporated as pathologic criterion for definite infective endocarditis into the 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis. To verify results from previous studies suggesting increased detection rates and to investigate the added diagnostic value of 16S rDNA PCR, we prospectively compared the diagnostic yield of a CE-IVD-marked 16S rDNA PCR assay to conventional culture (CC) in a large number of cardiac tissue samples, relating our findings to microbiological evidence from blood culture sampling and patient history. Over a seven-year period (2016-2023), 687 cardiac tissue samples were subjected to CC and 16S rDNA PCR. 16S rDNA PCR and CC yielded positive results in 326 (47.4 %) and 154 (22.4 %) samples, respectively. 136 (19.7 %) samples were concordantly tested positive. In 190 (27.7 %) and 18 (2.6 %) samples, a positive result was obtained only by PCR or CC. 343 (49.9 %) samples tested negative by both methods. In a case-based analysis of a subgroup of blood culture-confirmed IE (241 cases) and BC-negative non-IE cases (126 cases), 16S rDNA PCR yielded a diagnostic sensitivity and specificity of 74.7 % and 98.4 %, while CC yielded a sensitivity and specificity of 38.6 % and 99.2 %. In conclusion, the use of 16S rDNA PCR significantly increased the detection rate for bacteria in heart valve tissue. A notable proportion of the culture-negative samples contained pathogens that are generally not detectable by conventional culture. Therefore, supplementation of CC with 16S rDNA PCR is recommended for cardiac tissue samples, especially in case of blood culture-negative endocarditis.
Open AccessEvaluation of a commercial 16S rDNA PCR assay (UMD-SelectNA, Molzym) for pathogen detection from cardiac tissue specimens
The detection of bacteria in cardiac tissue, vegetations, or explanted prosthetic valves using nucleic acid amplification tests, such as 16S rDNA amplicon sequencing (16S rDNA PCR), has been incorporated as pathologic criterion for definite infective endocarditis into the 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis. To verify results from previous studies suggesting increased detection rates and to investigate the added diagnostic value of 16S rDNA PCR, we prospectively compared the diagnostic yield of a CE-IVD-marked 16S rDNA PCR assay to conventional culture (CC) in a large number of cardiac tissue samples, relating our findings to microbiological evidence from blood culture sampling and patient history. Over a seven-year period (2016-2023), 687 cardiac tissue samples were subjected to CC and 16S rDNA PCR. 16S rDNA PCR and CC yielded positive results in 326 (47.4 %) and 154 (22.4 %) samples, respectively. 136 (19.7 %) samples were concordantly tested positive. In 190 (27.7 %) and 18 (2.6 %) samples, a positive result was obtained only by PCR or CC. 343 (49.9 %) samples tested negative by both methods. In a case-based analysis of a subgroup of blood culture-confirmed IE (241 cases) and BC-negative non-IE cases (126 cases), 16S rDNA PCR yielded a diagnostic sensitivity and specificity of 74.7 % and 98.4 %, while CC yielded a sensitivity and specificity of 38.6 % and 99.2 %. In conclusion, the use of 16S rDNA PCR significantly increased the detection rate for bacteria in heart valve tissue. A notable proportion of the culture-negative samples contained pathogens that are generally not detectable by conventional culture. Therefore, supplementation of CC with 16S rDNA PCR is recommended for cardiac tissue samples, especially in case of blood culture-negative endocarditis.
- Open Access
- 8 December 2023
- Published by Springer Nature in Infection
- Vol. 52 (2) , 667-671
Population of invasive group A streptococci isolates from a German tertiary care center is dominated by the hypertoxigenic virulent M1UK genotype
Purpose: Hypertoxigenic Streptococcus pyogenes emm1 lineage M1UK has recently been associated with upsurges of invasive infections and scarlet fever in several countries, but whole-genome sequencing surveillance data of lineages circulating in Germany is lacking. In this study, we investigated recent iGAS isolates from our laboratory at a German tertiary care center for the presence of the M1UK lineage. Methods: Whole-genome sequencing was employed to characterize a collection of 47 consecutive non-copy isolates recovered from blood cultures (21) and tissue samples (26) in our laboratory between October 2022 and April 2023. Results: M protein gene (emm) typing distinguished 14 different emm types, with emm1 (17) being the dominant type. Single-nucleotide polymorphism (SNP) analysis confirmed the presence of all 27 SNPs characteristic for the M1UK lineage in 14 of 17 emm1 isolates. Conclusion: This study has shown for the first time that M1UK is present in Germany and might constitute a driving force in the observed surge of GAS infections. This observation mirrors developments in the UK and other countries and underscores the importance of WGS surveillance to understand the epidemiology of GAS.
- 8 December 2023
- Published by Springer Nature in Infection
- Vol. 52 (2) , 667-671
Open AccessPopulation of invasive group A streptococci isolates from a German tertiary care center is dominated by the hypertoxigenic virulent M1UK genotype
Purpose: Hypertoxigenic Streptococcus pyogenes emm1 lineage M1UK has recently been associated with upsurges of invasive infections and scarlet fever in several countries, but whole-genome sequencing surveillance data of lineages circulating in Germany is lacking. In this study, we investigated recent iGAS isolates from our laboratory at a German tertiary care center for the presence of the M1UK lineage. Methods: Whole-genome sequencing was employed to characterize a collection of 47 consecutive non-copy isolates recovered from blood cultures (21) and tissue samples (26) in our laboratory between October 2022 and April 2023. Results: M protein gene (emm) typing distinguished 14 different emm types, with emm1 (17) being the dominant type. Single-nucleotide polymorphism (SNP) analysis confirmed the presence of all 27 SNPs characteristic for the M1UK lineage in 14 of 17 emm1 isolates. Conclusion: This study has shown for the first time that M1UK is present in Germany and might constitute a driving force in the observed surge of GAS infections. This observation mirrors developments in the UK and other countries and underscores the importance of WGS surveillance to understand the epidemiology of GAS.
- Open Access
- 22 August 2023
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 16 (11) , 1806-1812
Comparative analysis of characteristics and outcomes in hospitalized COVID-19 patients infected with different SARS-CoV-2 variants between January 2020 and April 2022 – A retrospective single-center cohort study
- 22 August 2023
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 16 (11) , 1806-1812
Open AccessComparative analysis of characteristics and outcomes in hospitalized COVID-19 patients infected with different SARS-CoV-2 variants between January 2020 and April 2022 – A retrospective single-center cohort study
- 28 October 2021
- Published by Georg Thieme Verlag KG in Neuropediatrics
- Vol. 52 (S 01) , FV1.26
Development of the “Hamburg Best Practice Guidelines for ICV−Enzyme Replacement Therapy (ERT) in CLN2 Disease” Based on 6 Years of Treatment Experience in 48 Patients
Background: Intracerebroventricular enzyme replacement therapy (ICV-ERT) for CLN2 disease represents the first approved treatment for NCL diseases. It is the first treatment where a recombinant lysosomal enzyme, cerliponase alfa, is administered into the lateral cerebral ventricles to reach the central nervous system, the organ affected in CLN2 disease. If untreated, CLN2 children show first symptoms such as epilepsy and language developmental delay at 2 to 4 years followed by rapid loss of motor and language function, vision loss and early death. Treatment with cerliponase alfa has shown to slow down the rapid neurologic decline. However, the mode of administration by 4-hour-long ICV infusions every 14 days represents a potentially greater risk of infection compared to intravenous ERTs. The Hamburg NCL Specialty Clinic was the first site worldwide to perform ICV-ERT in children with CLN2 disease. Methods: In order to ensure maximum patient safety, we analyzed data from our center from more than 3,000 ICV-ERT in 48 patients over 6 years regarding the occurrence of device-related adverse events and device infections. Since starting ICV-ERTs, we have also developed and continuously improved the “Hamburg Best Practice Guidelines for ICV–Enzyme Replacement Therapy (ERT) in CLN2 Disease.” Results: The results of this study showed that the incidence of both malfunction and infection of the Rickham reservoirs was very low at 0.27 and 0.33%, respectively, compared to values in other studies in the literature. Conclusion: By following our internal procedural guidelines, standardization and patient safety of ICV-ERT for CLN2 disease can be improved. Publication Date: 28 October 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 28 October 2021
- Published by Georg Thieme Verlag KG in Neuropediatrics
- Vol. 52 (S 01) , FV1.26
Development of the “Hamburg Best Practice Guidelines for ICV−Enzyme Replacement Therapy (ERT) in CLN2 Disease” Based on 6 Years of Treatment Experience in 48 Patients
Background: Intracerebroventricular enzyme replacement therapy (ICV-ERT) for CLN2 disease represents the first approved treatment for NCL diseases. It is the first treatment where a recombinant lysosomal enzyme, cerliponase alfa, is administered into the lateral cerebral ventricles to reach the central nervous system, the organ affected in CLN2 disease. If untreated, CLN2 children show first symptoms such as epilepsy and language developmental delay at 2 to 4 years followed by rapid loss of motor and language function, vision loss and early death. Treatment with cerliponase alfa has shown to slow down the rapid neurologic decline. However, the mode of administration by 4-hour-long ICV infusions every 14 days represents a potentially greater risk of infection compared to intravenous ERTs. The Hamburg NCL Specialty Clinic was the first site worldwide to perform ICV-ERT in children with CLN2 disease. Methods: In order to ensure maximum patient safety, we analyzed data from our center from more than 3,000 ICV-ERT in 48 patients over 6 years regarding the occurrence of device-related adverse events and device infections. Since starting ICV-ERTs, we have also developed and continuously improved the “Hamburg Best Practice Guidelines for ICV–Enzyme Replacement Therapy (ERT) in CLN2 Disease.” Results: The results of this study showed that the incidence of both malfunction and infection of the Rickham reservoirs was very low at 0.27 and 0.33%, respectively, compared to values in other studies in the literature. Conclusion: By following our internal procedural guidelines, standardization and patient safety of ICV-ERT for CLN2 disease can be improved. Publication Date: 28 October 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 5 February 2021
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 17 (2) , e1009304
Distinct clonal lineages and within-host diversification shape invasive Staphylococcus epidermidis populations
S.epidermidisis a substantial component of the human skin microbiota, but also one of the major causes of nosocomial infection in the context of implanted medical devices. We here aimed to advance the understanding ofS.epidermidisgenotypes and phenotypes conducive to infection establishment. Furthermore, we investigate the adaptation of individual clonal lines to the infection lifestyle based on the detailed analysis of individualS.epidermidispopulations of 23 patients suffering from prosthetic joint infection. Analysis of invasive and colonizingS.epidermidisprovided evidence that invasiveS.epidermidisare characterized by infection-supporting phenotypes (e.g. increased biofilm formation, growth in nutrient poor media and antibiotic resistance), as well as specific genetic traits. The discriminating gene loci were almost exclusively assigned to the mobilome. Here, in addition to IS256and SCCmec, chromosomally integrated phages was identified for the first time. These phenotypic and genotypic features were more likely present in isolates belonging to sequence type (ST) 2. By comparing seven patient-matched nasal and invasiveS.epidermidisisolates belonging to identical genetic lineages, infection-associated phenotypic and genotypic changes were documented. Besides increased biofilm production, the invasive isolates were characterized by better growth in nutrient-poor media and reduced hemolysis. By examining several colonies grown in parallel from each infection, evidence for genetic within-host population heterogeneity was obtained. Importantly, subpopulations carrying IS insertions inagrC, mutations in the acetate kinase (AckA) and deletions in the SCCmecelement emerged in several infections. In summary, these results shed light on the multifactorial processes of infection adaptation and demonstrate howS.epidermidisis able to flexibly repurpose and edit factors important for colonization to facilitate survival in hostile infection environments.
- 5 February 2021
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 17 (2) , e1009304
Open AccessDistinct clonal lineages and within-host diversification shape invasive Staphylococcus epidermidis populations
S.epidermidisis a substantial component of the human skin microbiota, but also one of the major causes of nosocomial infection in the context of implanted medical devices. We here aimed to advance the understanding ofS.epidermidisgenotypes and phenotypes conducive to infection establishment. Furthermore, we investigate the adaptation of individual clonal lines to the infection lifestyle based on the detailed analysis of individualS.epidermidispopulations of 23 patients suffering from prosthetic joint infection. Analysis of invasive and colonizingS.epidermidisprovided evidence that invasiveS.epidermidisare characterized by infection-supporting phenotypes (e.g. increased biofilm formation, growth in nutrient poor media and antibiotic resistance), as well as specific genetic traits. The discriminating gene loci were almost exclusively assigned to the mobilome. Here, in addition to IS256and SCCmec, chromosomally integrated phages was identified for the first time. These phenotypic and genotypic features were more likely present in isolates belonging to sequence type (ST) 2. By comparing seven patient-matched nasal and invasiveS.epidermidisisolates belonging to identical genetic lineages, infection-associated phenotypic and genotypic changes were documented. Besides increased biofilm production, the invasive isolates were characterized by better growth in nutrient-poor media and reduced hemolysis. By examining several colonies grown in parallel from each infection, evidence for genetic within-host population heterogeneity was obtained. Importantly, subpopulations carrying IS insertions inagrC, mutations in the acetate kinase (AckA) and deletions in the SCCmecelement emerged in several infections. In summary, these results shed light on the multifactorial processes of infection adaptation and demonstrate howS.epidermidisis able to flexibly repurpose and edit factors important for colonization to facilitate survival in hostile infection environments.